CD63 and oral cavity squamous cell carcinoma: Our pilot study wanted to analyse the relationships between the plasmatic exosome levels, positive for either CD63 or CAV-1, in patients with stage 4 oral squamous cell carcinoma without distant metastasis or local bone invasion, before and after surgical treatment.